— Know what they know.
Not Investment Advice

HRMY NASDAQ

Harmony Biosciences Holdings, Inc.
1W: -0.9% 1M: -4.6% 3M: +4.6% YTD: -18.4% 1Y: -14.4% 3Y: -15.1% 5Y: +9.4%
$30.15
-0.34 (-1.12%)
 
Weekly Expected Move ±6.2%
$26 $28 $30 $32 $34
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 42 · $1.7B mcap · 50M float · 1.78% daily turnover · Short 61% of daily vol

📊 Key Metrics

TTM
$899M
Revenue
+20.7% YoY
$146M
Net Income
-4.7% YoY
$342M
Free Cash Flow
+54.4% YoY
79.3%
Gross Margin
17.3%
Op. Margin
15.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE19.0%
ROA12.8%
ROIC41.8%

Valuation

P/E12.0
P/B1.9
EV/EBITDA4.8

Leverage

Debt/Equity0.28
Current Ratio3.60
Interest Cov.14.8x

Quality Scores

Piotroski F6/9
Altman Z4.50
Beneish M-3.07

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms